I think you should read up on what it is like to live with asthma. Then you will understand the need for Respiri management tool which will use a smartphone to record datA on a daily basis using a hand held device.which monitors wheeze.
Resap is a tool that can diagnose what type of respiratory disease the person has when they present with a problem. They will cough into smart phone and a diagnosis is made. Is it pneumonia or is it a myriad of other problems including asthma? If asthma then they will require the Respri asthma management tool which will help them to manage their condition and hopefully reduce severe attacks.
Therefore imo they are not competitors but will be complementary.
Even if they were competing why try and make an issue here? Competition is healthy and is a natural part of business today.
- Forums
- ASX - By Stock
- VHL
- Ann: CEO Operational Review
VHL
vitasora health limited
Add to My Watchlist
3.57%
!
2.9¢

Ann: CEO Operational Review, page-10
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.9¢ |
Change
0.001(3.57%) |
Mkt cap ! $49.83M |
Open | High | Low | Value | Volume |
2.8¢ | 2.9¢ | 2.8¢ | $65.70K | 2.327M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1334508 | 2.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.0¢ | 414450 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1334508 | 0.029 |
4 | 4259096 | 0.028 |
6 | 1157037 | 0.027 |
3 | 295000 | 0.026 |
2 | 390000 | 0.025 |
Price($) | Vol. | No. |
---|---|---|
0.030 | 414450 | 4 |
0.031 | 1158579 | 3 |
0.032 | 1201050 | 3 |
0.033 | 300000 | 1 |
0.034 | 687500 | 3 |
Last trade - 16.10pm 17/07/2025 (20 minute delay) ? |
Featured News
VHL (ASX) Chart |